Page last updated: 2024-08-26

bismuth and Leukemia-Lymphoma, Adult T-Cell

bismuth has been researched along with Leukemia-Lymphoma, Adult T-Cell in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brechbiel, MW; Gansow, OA; Garmestani, K; Hartmann, F; Horak, EM; Kosteiny, SA; Kozak, RW; Nelson, DL; Tso, J; Wu, C1
Waldmann, TA2
Axworthy, DB; Brechbiel, MW; Carrasquillo, JA; Garmestani, K; Goldman, CK; Mallett, RW; Theodore, LJ; Waldmann, TA; Yao, Z; Zhang, M; Zhang, Z1

Reviews

2 review(s) available for bismuth and Leukemia-Lymphoma, Adult T-Cell

ArticleYear
Genetically engineered monoclonal antibodies armed with radionuclides.
    The Year in immunology, 1993, Volume: 7

    Topics: Animals; Antibodies, Monoclonal; Autoimmune Diseases; Bismuth; CD4 Antigens; CD4-Positive T-Lymphocytes; Gene Expression Regulation, Neoplastic; Humans; Immunotoxins; Leukemia-Lymphoma, Adult T-Cell; Mice; Neoplasm Proteins; Neoplasms; Protein Engineering; Radioimmunodetection; Radioimmunotherapy; Radioisotopes; Yttrium Radioisotopes

1993
Anti-IL-2 receptor monoclonal antibody (anti-Tac) treatment of T-cell lymphoma.
    Important advances in oncology, 1994

    Topics: ADP Ribose Transferases; Amino Acid Sequence; Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antibody Specificity; Antibody-Dependent Cell Cytotoxicity; Bacterial Toxins; Bismuth; Exotoxins; Gene Expression Regulation, Neoplastic; HTLV-I Infections; Humans; Immunologic Deficiency Syndromes; Immunotoxins; Leukemia-Lymphoma, Adult T-Cell; Mice; Molecular Sequence Data; Neoplasm Proteins; Protein Engineering; Pseudomonas aeruginosa Exotoxin A; Radioisotopes; Receptors, Interleukin-2; Virulence Factors; Yttrium Radioisotopes

1994

Other Studies

2 other study(ies) available for bismuth and Leukemia-Lymphoma, Adult T-Cell

ArticleYear
Radioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-Tac.
    Cancer research, 1994, Aug-15, Volume: 54, Issue:16

    Topics: Animals; Antibodies, Monoclonal; Bismuth; Dose-Response Relationship, Immunologic; Drug Screening Assays, Antitumor; Humans; Leukemia-Lymphoma, Adult T-Cell; Mice; Mice, Nude; Radioimmunotherapy; Radioisotopes; Radiotherapy Dosage; Receptors, Interleukin-2; Tissue Distribution

1994
Pretargeting radioimmunotherapy of a murine model of adult T-cell leukemia with the alpha-emitting radionuclide, bismuth 213.
    Blood, 2002, Jul-01, Volume: 100, Issue:1

    Topics: Alpha Particles; Animals; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biotin; Bismuth; Heterocyclic Compounds, 1-Ring; Leukemia-Lymphoma, Adult T-Cell; Mice; Mice, Inbred NOD; Neoplasms, Experimental; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Receptors, Interleukin-2; Streptavidin; Survival Rate; Treatment Outcome

2002